Blog
The Tiny Pump with Big Applications
BlogWe spoke to Tom Harrison, Business Development Manager, TTP Ventus, to learn more about the technology behind Disc Pump, and some of the applications it could benefit.
Read More
Tackling the Opioid Crisis: Genetic testing to identify addiction risk
BlogDr Keri Donaldson, CEO and founder of predictive health intelligence company Prescient Medicine, tells us about the role that genetic testing could play in tackling the opioid crisis.
Read More
Multiplex Testing Informs STI Treatment Pathways
BlogBacterial resistance to antibiotics is a growing concern, and is no less prevalent among pathogens causing sexually transmitted infections. Colin Denver tells us about the success of a multiplex diagnostics approach in testing azithromycin resistance in Mycoplasma genitalium.
Read More
How Metabolomic Biomarker Networks Could Help Diagnose Bladder Cancer
BlogWe spoke to Dr. Maximilian Zucker to learn more metabolomic biomarker networks and the role that they could play in the future of diagnostics.
Read More
Point-of-Care Testing for Peritoneal Dialysis Patients
BlogWe spoke to Barbara Fallowfield to learn about the test, the benefits it can offer patients, and the role that point-of-care tests may play in the future of healthcare.
Read More
First FDA Approval for NGS-based Companion Diagnostic
BlogTo learn about some of the challenges met in achieving FDA approval, the advantages the test offers, and how its use can benefit non-small cell lung cancer patients, we spoke to Joydeep Goswami, president of Clinical Next Generation Sequencing and Oncology at Thermo Fisher Scientific.
Read More
Data-Driven Medicine: The Role of AI in Cancer Diagnostics
BlogWe find out how SOPHiA™, a recently introduced artificial intelligence platform, could help improve the adoption of liquid biopsies in hospitals.
Read More
Driving Forward Companion Diagnostics Development
BlogWe spoke to Dr. Markus Tolnay and Mark Stevenson, to learn more about the NGS Companion Dx Center of Excellence Program and what it hopes to achieve.
Read More
The Role of Metabolomics in Diagnostics
BlogWe spoke to Volker Pfahlert, numares AG, to learn about the role of metabolomics in diagnostics and the advantages it can offer over current methods.
Read More
Improving Prostate & Bladder Cancer Diagnosis
BlogWe spoke to Nadia Whittley, CEO, Arquer Diagnostics, to learn about some of the current limitations of diagnosing bladder and prostate cancer, and how MCM5-ELISA tests could help.
Read More
Annual Conference on Antimicrobials and Drug Resistance
Sep 24 - Sep 25, 2018
